No offense but, your protest is emotional and not logical IMO... you inferred recently that the investors of CYDY were being played... Did you, or anyone else for that matter, truly believe CYDY would be able to report on the efficacy of Leronlimab last week? It doesn’t change my long-term opinion even though I’m not sure it’s realistic to get a full reporting of the data this week either... this goes back to one of my posts last week when I talked about communication styles. This would be a nothingburger last week if the expectations for receiving the results were more reasonable... in that regard, I agree Nader should do a better job of controlling his enthusiasm and stop throwing out unobtanium or subjective timelines that setup investors for disappointment... with regards to the safety data being reported, Nader was accompanied by multiple people on the press release and on the follow up call. Dr. Jay even indicated the significance of that data alone could be considered efficacy vs the placebo. Meaning Leronlimab caused significantly less harm to its patients than the placebo... those results are also a strong indicator that the efficacy results will be equally impressive. I personally had no issue with the timing of the safety data release and I was very impressed by how significant those results were... if you’re going to be transparent, you present the data you have when you obtain it... but, like many, I believe the pr could have been better worded.
Did you consider yourself an investor or situational trader in CYDY when you made that trade last week? What’s your position if the efficacy results come back as significantly better than the placebo? Stock likely doubles or triples immediately... What about HIV, Cancer, etc...?
News 
Market Data 
Discover 
